These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2972439)

  • 1. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 2. [A double-blind comparison of a sulfurated mucopolysaccharide and placebo in the treatment of elderly patients with cerebrovascular insufficiency].
    Astengo F; Fontana L; Balestreri R
    Clin Ter; 1987 Feb; 120(3):219-26. PubMed ID: 2461828
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders.
    Agnoli A; Manna V; Martucci N; Fioravanti M; Ferromilone F; Cananzi A; D'Andrea G; De Rosa A; Vizioli R; Sinforiani E
    Int J Clin Pharmacol Res; 1988; 8(3):189-97. PubMed ID: 3042644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology].
    Corso EA; Arena M; Ventimiglia A; Bizzarro G; Campo G; Rodolico F
    Clin Ter; 1982 Aug; 102(4):379-86. PubMed ID: 6754218
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
    Bargheon J; Durocher AM; Lagrange M
    Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Betahistine in peripheral vertigo: a double-blind, placebo-controlled, cross-over study of Serc versus placebo.
    Canty P; Valentine J
    J Laryngol Otol; 1981 Jul; 95(7):687-92. PubMed ID: 7019369
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical double blind study with the calcium antagonist flunarizine cerebral circulatory disturbances].
    Eckmann F
    Arzneimittelforschung; 1985; 35(8):1276-9. PubMed ID: 3907638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3GS prevention and therapy of transient cerebral ischemic attacks in the aged].
    Mancini M; Dall'Asta D; Maini C; Cucinotta D
    G Clin Med; 1983; 64(1-2):51-65. PubMed ID: 6345252
    [No Abstract]   [Full Text] [Related]  

  • 9. [Instrumental evaluation of the effects of mesoglycan in venous disease patients. A prospective randomized double-blind study].
    de Donato G; Sangiuolo P
    Minerva Med; 1986 Oct; 77(41):1927-31. PubMed ID: 2946988
    [No Abstract]   [Full Text] [Related]  

  • 10. [Per os effects of bepridil on venous compliance in a controlled double-blind cross-over trial versus placebo].
    Bailliart O; Tessera M; Martineaud JP; Castan D
    Therapie; 1986; 41(5):385-90. PubMed ID: 3544320
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parallel double-blind clinical trial of nifedipine versus a placebo in patients with chronic cerebrovascular insufficiency].
    Vintró Molins C; Viaplana Más JM
    Med Clin (Barc); 1985 Mar; 84(8):308-11. PubMed ID: 3884927
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind placebo controlled cross-over study on cimetidine--prophylactic effect in patients under steroid treatment. Preliminary data.
    Camarri E; Chirone E; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):258-60. PubMed ID: 7005121
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 15. [Double-blind cross-over clinical study of a new psychopharmaceutic agent: thiadipone (QM-6008), diazepam and a placebo].
    Conde López V
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1980; 8(6):409-42. PubMed ID: 7008536
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
    Otomo E; Araki G; Mori A; Kurihara M
    Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
    Kellner H
    MMW Munch Med Wochenschr; 1976 Oct; 118(43):1399-1402. PubMed ID: 825745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of naloxone on acute stroke.
    Czlonkowska A; Cyrta B
    Pharmacopsychiatry; 1988 Mar; 21(2):98-100. PubMed ID: 3293092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A double-blind clinical trial of a topical preparation with a base of biochemical precursors of glucosaminoglycan (GAG) in patients suffering from Raynaud's disease].
    Signorini GP
    Boll Chim Farm; 1986 Oct; 125(10):103S-110S. PubMed ID: 3551995
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness.
    Hargreaves J
    Practitioner; 1980 May; 224(1343):547-50. PubMed ID: 6999486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.